Hirudoid Forte (Chondroitin Sulfate Sodium)

Hirudoid Forte is commonly employed in the topical management of joint discomfort related to osteoarthritis and other degenerative joint conditions.

• Relief of mild to moderate knee joint pain associated with osteoarthritis.
• Reduction of stiffness and improved joint mobility in the hands or elbows.
• Adjunctive therapy for early‑stage osteoarthritis when systemic NSAIDs are contraindicated.
• Support of cartilage health through external application of sulfated glycosaminoglycans.
• Use as a symptomatic treatment for localized joint swelling in the feet or hips.
• Application on the lower back to alleviate discomfort from facet joint degeneration.

• Chondroitin sulfate sodium is a sulfated glycosaminoglycan that serves as a building block of cartilage extracellular matrix. When applied topically, it penetrates the dermal layers and supplies sulfated chains that can be incorporated into proteoglycans, supporting matrix synthesis. The compound may also inhibit enzymes such as metalloproteinases that degrade cartilage, thereby helping to preserve joint structure and reduce inflammatory mediators locally.

Topical application of Hirudoid Forte may be associated with local skin reactions and, rarely, systemic effects.

Common

• Mild erythema or redness at the application site.
• Transient itching or pruritus.
• Slight burning sensation during or after application.
• Dryness or peeling of the skin.
• Mild tingling sensation without lasting discomfort.
• Temporary discoloration of the skin (e.g., slight brownish hue).

Serious

• Allergic contact dermatitis with vesicular rash.
• Severe swelling or edema of the treated area.
• Systemic hypersensitivity reactions such as urticaria.
• Persistent ulceration or infection at the site.
• Rare occurrence of systemic allergic symptoms such as fever or malaise.
• Development of necrotic skin lesions requiring medical attention.

When using Hirudoid Forte, certain precautions should be observed to minimize the risk of adverse reactions and ensure safe application.

• Perform a patch test on a small skin area before first use.
• Avoid applying to broken, inflamed, or infected skin.
• Do not use on mucous membranes, eyes, or genital areas.
• Keep the product out of reach of children; accidental ingestion may cause unknown effects.
• Discontinue use and seek medical advice if signs of allergic reaction develop.
• Store at room temperature, protected from excessive heat and direct sunlight.

Topical chondroitin sulfate may interact with certain substances; awareness of these interactions helps avoid reduced efficacy or increased irritation.

Avoid

• Concurrent use of other topical irritants such as strong corticosteroids or retinoids on the same area.
• Application over skin treated with chemical peels or laser therapy.

Use with caution

• Use together with systemic chondroitin supplements; monitor for cumulative effects.
• Combine with NSAID gels; observe for additive skin irritation.
• Apply in conjunction with wound dressings; ensure the area is clean and dry.
• Use while wearing occlusive bandages; may increase absorption and risk of local reactions.